About Johanna Friedl-Naderer
Johanna Friedl-Naderer is a chief commercial officer at Dyne Therapeutics.
Form D filings name Johanna Friedl-Naderer as a director at Encentrio Therapeutics.
Johanna Friedl-Naderer reports to the SEC as an officer of 2 public companies, including Vir Biotechnology (VIR).
Johanna Friedl-Naderer first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Johanna Friedl-Naderer in the role, so the role may have started earlier or lasted longer.
DI
Dyne Therapeutics, Inc.
Chief Commercial Officer
2024 – 2026 · Public company (DYN)
VI
Vir Biotechnology, Inc.
EVP & Chief Operating Officer
2022 – 2023 · Public company (VIR)
Key Colleagues at Startups
The people Johanna Friedl-Naderer works with at each company, as listed on that company's latest Form D.
Encentrio Therapeutics, Inc. · Form D, Apr 3, 2023
TH
Thomas Hecht
Director
GS
George Scangos
Director
SL
Sung Lee
Executive officer and director
NS
Natascha Schill
Chief Executive Officer and director
VV
Vanina de Verneuil
Executive officer